Microbial threat lists: Obstacles in the quest for biosecurity?

Nature Reviews Microbiology

Volumn 8, Issue 2, 2010, Pages 149-154

  Casadevall, Arturo ^a   Relman, David A ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; BACTERIAL TOXIN; BOTULINUM TOXIN; RICIN; TOXIN;

BACILLUS ANTHRACIS; BACILLUS CEREUS; BACTERIAL VIRULENCE; BIOLOGICAL WARFARE AGENT; BIOSAFETY; BURKHOLDERIA PSEUDOMALLEI; COCCIDIOIDES; EPIDEMIC; FRANCISELLA TULARENSIS; GOVERNMENT REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA VIRUS A H1N1; LAW ENFORCEMENT; MICROBIAL POPULATION DYNAMICS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SACCHAROMYCES CEREVISIAE; SEVERE ACUTE RESPIRATORY SYNDROME; UNITED STATES; VIRUS TRANSMISSION; ZOONOSIS; ANIMAL; ARTICLE; BACTERIUM; BIOLOGICAL WARFARE; CLASSIFICATION; LEGAL ASPECT; MEDLINE; ORGANIZATION AND MANAGEMENT; PATHOGENICITY; VIRUS;

ANIMALS; BACILLUS ANTHRACIS; BACTERIA; BIOTERRORISM; HUMANS; PUBMED; SECURITY MEASURES; TOXINS, BIOLOGICAL; UNITED STATES; VIRUSES;

EID: 75749092644     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro2299     Document Type: Review

References (40)

1. CDC & US Department of Health and Human Services. Possession, use, and transfer of select agents and toxins. Final rule. Fed. Regist. 73, 61363-61366 (2008)
2. WHO. Biorisk management: Laboratory biosecurity guidance. World Health Organization [online] http:// www.who.int/csr/resources/publications/biosafety/ WHO-CDS-EPR-2006-6.pdf (2006).
3. Sewell, D. L. Laboratory safety practices associated with potential agents of biocrime or bioterrorism. J. Clin. Microbiol. 41, 2801-2809 (2003).
4. Bhattacharjee, Y. & Enserink, M. Anthrax investigation: FBI discusses microbial forensics-but key questions remain unanswered. Science 321, 1026-1027 (2008).
5. Himsworth, C. G. & Argue, C. K. Clinical impressions of anthrax from the 2006 outbreak in Saskatchewan. Can. Vet. J. 50, 291-294 (2009).
6. Ma, G., Zheng, D., Cai, Q. & Yuan, Z. Prevalence of Burkholderia pseudomallei in Guangxi, China. Epidemiol. Infect. 138, 37-39 (2009)
7. US Department of Agriculture. Agricultural Bioterrorism Protection Act of 2002. Possession, use, and transfer of biological agents and toxins. Final rule. Fed. Regist. 70, 13242-13292 (2005).
8. Mathew, M. & Verma, R. S. Humanized immunotoxins: a new generation of immunotoxins for targeted cancer therapy. Cancer Sci. 100, 1359-1365 (2009).
9. Schneerson, R. et al. Poly(γ-d-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine. Proc. Natl Acad. Sci. USA 100, 8945-8950 (2003).
10. Kenefic, L. J. et al. High resolution genotyping of Bacillus anthracis outbreak strains using four highly mutable single nucleotide repeat markers. Lett. Appl. Microbiol. 46, 600-603 (2008).
11. Cohan, F. M. What are bacterial species? Annu. Rev. Microbiol. 56, 457-487 (2002).
12. Gevers, D. et al. Re-evaluating prokaryotic species. Nature Rev. Microbiol. 3, 733-739 (2005).
13. Konstantinidis, K. T. & Tiedje, J. M. Genomic insights that advance the species definition for prokaryotes. Proc. Natl Acad. Sci. USA 102, 2567-2572 (2005).
14. Christensen, H., Kuhnert, P., Busse, H. J., Frederiksen, W. C. & Bisgaard, M. Proposed minimal standards for the description of genera, species and subspecies of the Pasteurellaceae. Int. J. Syst. Evol. Microbiol. 57, 166-178 (2007).
15. Sheppard, S. K., McCarthy, N. D., Falush, D. & Maiden, M. C. Convergence of Campylobacter species: implications for bacterial evolution. Science 320, 237-239 (2008).
16. Yu, G. X. Pathogenic Bacillus anthracis in the progressive gene losses and gains in adaptive evolution. BMC Bioinformatics 10 (Suppl. 1), S3 (2009).
17. Marston, C. K., Gee, J. E., Popovic, T. & Hoffmaster, A. R. Molecular approaches to identify and differentiate Bacillus anthracis from phenotypically similar Bacillus species isolates. BMC Microbiol. 6, 22 (2006).
18. Hoffmaster, A. R. et al. Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. Proc. Natl Acad. Sci. USA 101, 8449-8454 (2004).
19. Hoffmaster, A. R. et al. Characterization of Bacillus cereus isolates associated with fatal pneumonias: strains are closely related to Bacillus anthracis and harbor B. anthracis virulence genes. J. Clin. Microbiol. 44, 3352-3360 (2006).
20. Okinaka, R., Pearson, T. & Keim, P. Anthrax, but not Bacillus anthracis? PLoS Pathog. 2, e122 (2006).
21. Hu, X., Van der Auwera, G., Timmery, S., Zhu, L. & Mahillon, J. Distribution, diversity, and potential mobility of extrachromosomal elements related to the Bacillus anthracis pXO1 and pXO2 virulence plasmids. Appl. Environ. Microbiol. 75, 3016-3028 (2009).
22. Ivanova, N. et al. Genome sequence of Bacillus cereus and comparative analysis with Bacillus anthracis. Nature 423, 87-91 (2003).
23. Casadevall, A. & Pirofski, L. The weapon potential of a microbe. Trends Microbiol. 12, 259-263 (2004).
24. Ogawa, H., Fujimura, M. & Tofuku, Y. Allergic bronchopulmonary fungal disease caused by Saccharomyces cerevisiae. J. Asthma 41, 223-228 (2004).
25. Ren, P., Sridhar, S. & Chaturvedi, V. Use of paraffin-embedded tissue for identification of Saccharomyces cerevisiae in a baker's lung nodule by fungal PCR and nucleotide sequencing. J. Clin. Microbiol. 42, 2840-2842 (2004).
26. Casadevall, A. & Pirofski, L. Host-pathogen interactions: the attributes of virulence. J. Infect. Dis. 184, 337-344 (2001)
27. CDC & US Department for Health and Human Services. Possession, use, and transfer of select agents and toxins-reconstructed replication competent forms of the 1918 pandemic influenza virus containing any portion of the coding regions of all eight gene segments. Interim final rule. Fed. Regist. 70, 61047-61049 (2005).
28. Morens, D. M., Taubenberger, J. K. & Fauci, A. S. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 198, 962-970 (2008).
29. Tumpey, T. M. et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310, 77-80 (2005).
30. Raman, T. & Marik, P. E. Fungal infections in bone marrow transplant recipients. Expert. Opin. Pharmacother. 7, 307-315 (2006).
31. Park, B. J. et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23, 525-530 (2009).
32. Rotz, L. D., Khan, A. S., Lillibridge, S. R., Ostroff, S. M. & Hughes, J. M. Public health assessment of potential biological terrorism agents. Emerg. Infect. Dis. 8, 225-230 (2002).
33. Feldbaum, H., Lee, K. & Patel, P. The national security implications of HIV/AIDS. PLoS. Med. 3, e171 (2006).
34. Casadevall, A. & Pirofski, L. A. The weapon potential of human pathogenic fungi. Med. Mycol. 44, 689-696 (2006).
35. Furcolow, M. L. Airborne histoplasmosis. Bacteriol. Rev. 25, 301-309 (1961).
36. Heymann, D. L. The international response to the outbreak of SARS in 2003. Phil. Trans. R. Soc. Lond. B 359, 1127-1129 (2004)
37. CDC & US Department of Health and Human Services. Possession, use, and transfer of Select Agents and Toxins. Proposed addition of SARS-associated coronavirus (SARS-CoV). Fed. Regist. 74, 33401-33403 (2009).
38. Relman, D. A. Bioterrorism-preparing to fight the next war. N. Engl. J. Med. 354, 113-115 (2006)
39. US National Science Advisory Board for Biosecurity. Addressing biosecurity concerns related to the synthesis of Select Agents. Office of Biotechnology Activities-US National Institutes of Health [online] http://oba.od.nih.gov/biosecurity/pdf/Final-NSABB- Report-on-Synthetic-Genomics. pdf (2009)
40. US National Science Advisory Board for Biosecurity. Enhancing personal reliability among individuals with access to select agents. Office of Biotechnology Activities-US National Institutes of Health [online] http://oba.od.nih.gov/biosecurity/ meetings/200905T/NSABB Final Report on PR 5-29-09.pdf (2009).